{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T16:40:12Z","timestamp":1740156012967,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Musculoskelet Surg"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s12306-023-00799-6","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T20:01:22Z","timestamp":1699473682000},"page":"93-98","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of denosumab in treatment of unresectable spine and sacrum giant cell tumor of bone"],"prefix":"10.1007","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3164-758X","authenticated-orcid":false,"given":"A.","family":"Arefpour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8418-8079","authenticated-orcid":false,"given":"M.","family":"Shafieesabet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3068-9764","authenticated-orcid":false,"given":"M.","family":"Chehrassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3433-7202","authenticated-orcid":false,"given":"A.","family":"Ahmadzadehnanva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Ghandhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"issue":"24","key":"799_CR1","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.3390\/cancers13246298","volume":"13","author":"A Parmeggiani","year":"2021","unstructured":"Parmeggiani A, Miceli M, Errani C, Facchini GJC (2021) State of the art and new concepts in giant cell tumor of bone: imaging features and tumor characteristics. Cancers 13(24):6298","journal-title":"Cancers"},{"issue":"1","key":"799_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.nec.2007.09.009","volume":"19","author":"N Luther","year":"2008","unstructured":"Luther N, Bilsky MH, H\u00e4rtl R (2008) Giant cell tumor of the spine. Neurosurg Clin N Am 19(1):49\u201355","journal-title":"Neurosurg Clin N Am"},{"key":"799_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s00292-020-00760-5","volume":"41","author":"A Roessner","year":"2020","unstructured":"Roessner A, Smolle M, Hayb\u00e4ck J (2020) Giant cell tumor of bone: Morphology, molecular pathogenesis, and differential diagnosis. Pathologe 41:134\u2013142","journal-title":"Pathologe"},{"issue":"2","key":"799_CR4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3928\/01477447-20140124-08","volume":"37","author":"DF Amanatullah","year":"2014","unstructured":"Amanatullah DF, Clark TR, Lopez MJ, Borys D, Tamurian RM (2014) Giant cell tumor of bone. Orthopedics 37(2):112\u2013120","journal-title":"Orthopedics"},{"issue":"10","key":"799_CR5","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1007\/s00586-021-06963-5","volume":"30","author":"G Facchini","year":"2021","unstructured":"Facchini G, Parmeggiani A, Peta G, Martella C, Gasbarrini A, Evangelisti G et al (2021) The role of percutaneous transarterial embolization in the management of spinal bone tumors: a literature review. Eur Spine J. 30(10):2839\u20132851","journal-title":"Eur Spine J."},{"issue":"2","key":"799_CR6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.5435\/JAAOS-21-02-118","volume":"21","author":"KA Raskin","year":"2013","unstructured":"Raskin KA, Schwab JH, Mankin HJ, Springfield DS, Hornicek FJ (2013) Giant cell tumor of bone. JAAOS-J Am Acad Orthop Surg. 21(2):118\u2013126","journal-title":"JAAOS-J Am Acad Orthop Surg."},{"unstructured":"Siegal G, Bloem J, Cates JM (2020) WHO classification of tumors 5th Edition soft tissue and bone tumors. WHO Geneva, Switzerland","key":"799_CR7"},{"issue":"6","key":"799_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12094-014-1268-5","volume":"17","author":"A L\u00f3pez-Pousa","year":"2015","unstructured":"L\u00f3pez-Pousa A, Broto JM, Garrido T, V\u00e1zquez JJC, Oncology T (2015) Giant cell tumor of bone: new treatments in development. Clin Transl Oncol. 17(6):419\u2013430","journal-title":"Clin Transl Oncol."},{"key":"799_CR9","doi-asserted-by":"publisher","first-page":"151479","DOI":"10.1016\/j.anndiagpath.2020.151479","volume":"45","author":"MU Tariq","year":"2020","unstructured":"Tariq MU, Umer M, Khan Z, Saeed J, Siddiqui MA, Din NU (2020) Spectrum of histological features of Denosumab treated giant cell tumor of bone; potential pitfalls and diagnostic challenges for pathologists. Ann Diagn Pathol. 45:151479","journal-title":"Ann Diagn Pathol."},{"key":"799_CR10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s13277-015-3094-y","volume":"36","author":"PF Wu","year":"2015","unstructured":"Wu PF, Tang JY, Li KH (2015) RANK pathway in giant cell tumor of bone: pathogenesis and therapeutic aspects. Tumor Biol. 36:495\u2013501","journal-title":"Tumor Biol."},{"issue":"1","key":"799_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12957-018-1478-3","volume":"16","author":"J Engellau","year":"2018","unstructured":"Engellau J, Seeger L, Grimer R, Henshaw R, Gelderblom H, Choy E et al (2018) Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone. World J Surg Oncol. 16(1):1\u20139","journal-title":"World J Surg Oncol."},{"issue":"2","key":"799_CR12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228\u2013247","journal-title":"Eur J Cancer"},{"issue":"13","key":"799_CR13","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1200\/JCO.2006.07.3049","volume":"25","author":"H Choi","year":"2007","unstructured":"Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR et al (2007) Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 25(13):1753\u20131759","journal-title":"J Clin Oncol"},{"key":"799_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00586-019-05997-0","volume":"29","author":"S Boriani","year":"2020","unstructured":"Boriani S, Cecchinato R, Cuzzocrea F, Bandiera S, Gambarotti M, Gasbarrini A (2020) Denosumab in the treatment of giant cell tumor of the spine. Preliminary report, review of the literature and protocol proposal. Eur Spine J 29:257\u2013271","journal-title":"Eur Spine J"},{"issue":"1","key":"799_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13244-020-00845-y","volume":"11","author":"M Alothman","year":"2020","unstructured":"Alothman M, Althobaity W, Asiri Y, Alreshoodi S, Alismail K, Alshaalan M (2020) Giant cell tumor of bone following denosumab treatment: assessment of tumor response using various imaging modalities. Insights Imaging 11(1):1\u20136","journal-title":"Insights Imaging"},{"key":"799_CR16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejca.2017.01.028","volume":"76","author":"E Palmerini","year":"2017","unstructured":"Palmerini E, Chawla N, Ferrari S, Sudan M, Picci P, Marchesi E et al (2017) Denosumab in advanced\/unresectable giant-cell tumour of bone (GCTB): for how long? Eur J Cancer. 76:118\u2013124","journal-title":"Eur J Cancer."},{"issue":"5","key":"799_CR17","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3171\/2014.10.SPINE13937","volume":"22","author":"T Goldschlager","year":"2015","unstructured":"Goldschlager T, Dea N, Boyd M, Reynolds J, Patel S, Rhines LD et al (2015) Giant cell tumors of the spine: Has denosumab changed the treatment paradigm? J Neurosurg Spine 22(5):526\u2013533","journal-title":"J Neurosurg Spine"},{"issue":"3","key":"799_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1470-2045(10)70010-3","volume":"11","author":"D Thomas","year":"2010","unstructured":"Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay J-Y et al (2010) Denosumab in patients with giant-cell tumour of bone: an open-label phase 2 study. Lancet Oncol 11(3):275\u2013280","journal-title":"Lancet Oncol"},{"key":"799_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013139","author":"Y Yang","year":"2018","unstructured":"Yang Y, Li Y, Liu W, Xu H, Niu XJM (2018) A nonrandomized controlled study of sacral giant cell tumors with preoperative treatment of Denosumab. Medicine. https:\/\/doi.org\/10.1097\/MD.0000000000013139","journal-title":"Medicine"},{"issue":"16","key":"799_CR20","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1158\/1078-0432.CCR-12-0578","volume":"18","author":"DG Branstetter","year":"2012","unstructured":"Branstetter DG, Nelson SD, Manivel JC, Blay J-Y, Chawla S, Thomas DM et al (2012) Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone. Clin Cancer Res 18(16):4415\u20134424","journal-title":"Clin Cancer Res"},{"issue":"9","key":"799_CR21","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.3390\/cancers14092290","volume":"14","author":"AM Borkowska","year":"2022","unstructured":"Borkowska AM, Szumera-Cie\u0107kiewicz A, Szostakowski B, Pie\u0144kowski A, Rutkowski PL (2022) Denosumab in giant cell tumor of bone: multidisciplinary medical management based on pathophysiological mechanisms and real-world evidence. Cancers 14(9):2290","journal-title":"Cancers"},{"issue":"5","key":"799_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/BRS.0000000000003728","volume":"46","author":"SV Bukata","year":"2021","unstructured":"Bukata SV, Blay J-Y, Rutkowski P, Skubitz K, Henshaw R, Seeger L, Dai T, Jandial D, Chawla S (2021) Denosumab treatment for giant cell tumor of the spine including the sacrum. Spine 46(5):277","journal-title":"Spine"}],"container-title":["MUSCULOSKELETAL SURGERY"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12306-023-00799-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12306-023-00799-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12306-023-00799-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T03:11:23Z","timestamp":1708571483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12306-023-00799-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["799"],"URL":"https:\/\/doi.org\/10.1007\/s12306-023-00799-6","relation":{},"ISSN":["2035-5106","2035-5114"],"issn-type":[{"type":"print","value":"2035-5106"},{"type":"electronic","value":"2035-5114"}],"subject":[],"published":{"date-parts":[[2023,11,8]]},"assertion":[{"value":"21 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human or animal participants"}}]}}